CEO Michael Kauffman sold $447K of Karyopharm Therapeutics Inc.

Sold$447,381

$22.37Price

20,000Shares

−2%Stake

What KPTI did after the filing

Prices for KPTI after this filing aren't in yet.

Traded Tue, Mar 10. Filed Wed, Mar 11, 3:07 PM ET, during the session. Not investment advice.